PAIGE.AI, Inc.
Acquired
Matched to this startup by its exact name; the buyer's report is the source.
| Acquired | Buyer | Acquisition date | Completion | Price | Stake | Source |
|---|---|---|---|---|---|---|
| Paige.AI, Inc | Tempus AI, Inc. | 2025 | — | $102 M | — | Annual report |
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Mar 2023 | $20 M | No. 3 | $10 to $50 million | equity, options | SEC | |
| Jan 2021 | $55 M | No. 2 | $50 to $250 million | equity | SEC | |
| Nov 2019 | $71 M | No. 1 | $50 to $250 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
PAIGE.AI, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2023).
SEC Form D · Mar 2023
The industry group it chose in its notices: Other Health Care.
SEC Form D · Mar 2023
That is all the official record says: PAIGE.AI, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of PAIGE.AI, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 26 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Christina Andrew Segro | Executive officer | Mar 2023 |
| David Andrew Andreasson | Executive officer | Mar 2023 |
| David Andrew Klimstra | Executive officer | Mar 2023 |
| Peter Andrew Hamilton | Executive officer | Mar 2023 |
| William Andrew Moye | Executive officer | Mar 2023 |
| Carla Martin Leibowitz | Executive officer | Jan 2021 |
| Leo Grady | Executive officer | Jan 2021 |
| Carla Leibowitz | Executive officer | Jul 2020 |
| Thomas Fuchs | Executive officer | Jul 2020 |
| Ali Andrew Satvat | Director | Mar 2023 |
| Antoine Andrew Munfa | Director | Mar 2023 |
| Asish Andrew Xavier | Director | Mar 2023 |
| Eli Andrew Casdin | Director | Mar 2023 |
| Hedvig Andrew Hricak, M.D., Ph.D. | Director | Mar 2023 |
| Jeffrey Andrew Lightcap | Director | Mar 2023 |
| Jim Andrew Beyer | Director | Mar 2023 |
| Kenan Andrew Turnacioglu | Director | Mar 2023 |
| Robert Andrew Galvin | Director | Mar 2023 |
| Thomas Andrew Fuchs | Director | Mar 2023 |
| William Andrew Moye | Director | Mar 2023 |
| Asish Xavier | Director | Jan 2021 |
| David Castelblanco | Director | Jan 2021 |
| Eli Martin Casdin | Director | Jan 2021 |
| Jeffrey Lightcap | Director | Jan 2021 |
| Jim Breyer | Director | Jan 2021 |
| Kenan Turnacioglu | Director | Jan 2021 |
| Leo Grady | Director | Jan 2021 |
| R. Martin Chavez | Director | Jan 2021 |
| Robert Galvin | Director | Jan 2021 |
| Thomas Fuchs | Director | Jan 2021 |
| Thomas Kelly | Director | Jan 2021 |
| Martin Chavez | Director | Jul 2020 |
| Alex Robertson | Director | Nov 2019 |
| Eric Cottington | Director | Nov 2019 |
| Norman Selby | Director | Nov 2019 |
Acquired (Jan 1, 2025). Acquired by Tempus AI, Inc..